{
    "construct_crystal": {
        "uniprot": "grm5_human",
        "ligand_conc_unit": "\u03bcM",
        "ligand_id": "CHEMBL1270399",
        "ligand_activity": "nam",
        "pdb_name": "5cgd_partial",
        "ligand_name": "Compound 25",
        "ligand_id_type": "ChEMBL Compound ID",
        "ligand_conc": "100",
        "pdb": "5CGD"
    },
    "unparsed": {
        "mut_remark_3": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations",
        "time_expr": "48 hours",
        "mut_remark_4": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations",
        "mut_remark_7": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations",
        "mut_remark_2": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations",
        "other_signal_2": "GP64",
        "mut_remark_5": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations",
        "mut_remark_6": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations"
    },
    "auxiliary": {
        "aux4": {
            "presence": "YES",
            "position": "C-term",
            "subtype": "His(10)",
            "type": "tag"
        },
        "aux2": {
            "presence": "YES",
            "position": "N-term",
            "subtype": "Other",
            "type": "signal"
        },
        "aux3": {
            "presence": "YES",
            "position": "Within Receptor",
            "subtype": "T4 Lysozyme (T4L)",
            "type": "fusion"
        }
    },
    "expression": {
        "expr_method": "Baculovirus",
        "expr_remark": "FastBac",
        "host_cell": "Insect",
        "host_cell_type": "Sf21"
    },
    "raw_data": {
        "protein_type_3": "fusion",
        "other_lig_id": "",
        "concentr": "",
        "other_lig_act": "",
        "protein_conc_unit": "mg/ml",
        "expr_method": "Baculovirus",
        "presence_expr": "",
        "url": "gpcrdb.org",
        "signal": "",
        "aamod_end": "",
        "protein_id_4": "",
        "time_expr": "48 hours",
        "expr_remark": "FastBac",
        "protein_type": "",
        "ph": "range_ph",
        "deterg_type": "DDM",
        "protein_id": "",
        "position_3": "Within Receptor",
        "aamod_single_2": "",
        "ligand_conc": "100",
        "ins_start_2": "",
        "pi_name": "gpcrdb",
        "undefined_2": "",
        "aamod_end_2": "",
        "host_cell": "Insect",
        "linker_seq_2": "",
        "aamod_start_2": "",
        "mut_aa_5": "M",
        "lipid": "",
        "mod_remark_2": "L-cystine",
        "delet_start_4": "832",
        "protein_id_type_2": "",
        "tag_3": "",
        "wt_aa_6": "T",
        "deletion_4": "del_range",
        "fusion_prot_3": "T4 Lysozyme (T4L)",
        "ins_end_4": "",
        "other_method": "two syringue method ",
        "ins_start": "",
        "protein_type_4": "tag",
        "concentr_4": "24-34",
        "prot_cleavage_4": "",
        "protein_id_3": "",
        "other_signal": "",
        "protein_concentr": "50",
        "other_prot_cleavage_2": "",
        "ligand_activity": "nam",
        "lcp_add": "cholesterol ",
        "other_lcp_lipid": "",
        "mut_type_6": "Thermostabilising",
        "aamod_pair_two_2": "733",
        "lcp_conc": "1:10",
        "aa_no": "",
        "mut_aa_7": "A",
        "ligand_conc_unit": "\u03bcM",
        "ins_end_2": "",
        "ligand_id_type": "ChEMBL Compound ID",
        "signal_3": "",
        "deletion_single_4": "",
        "protein_id_2": "",
        "delet_start": "",
        "protein_type_2": "signal",
        "host_cell_type": "Sf21",
        "insert_pos_type_2": "",
        "concentr_unit_5": "\u03bcM",
        "insert_pos_type": "",
        "deletion": "",
        "concentr_3": "100-250",
        "insert_pos_single_3": "",
        "mod_remark": "",
        "address": "\t\t\t\t\t\t\t",
        "prot_cleavage_3": "",
        "wt_aa_2": "E",
        "pdb": "5CGD",
        "pdb_name": "5cgd_partial",
        "deterg_conc": "",
        "other_lipid": "",
        "crystal_type": "lipidic cubic phase (LCP)",
        "insert_pos_type_3": "ins_range",
        "mut_type_4": "Thermostabilising",
        "position_4": "C-term",
        "aamod_pair_one": "",
        "chemical_comp": "",
        "mut_remark_7": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations",
        "addit_concentr_unit": "0",
        "mut_type_7": "Thermostabilising",
        "other_signal_2": "GP64",
        "aamod_position_2": "pair",
        "solub_additive": "none",
        "presence_3": "YES",
        "ph_single": "",
        "pi_email": "info@gpcrdb.org",
        "mut_type_3": "Thermostabilising",
        "aamod_pair_two": "",
        "wt_aa_5": "G",
        "linker_seq": "",
        "chemical_comp_2": "MES",
        "position": "",
        "ph_range_two": "6.8",
        "signal_2": "Other",
        "mut_remark_2": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations",
        "insert_pos_single_2": "",
        "chemical_comp_3": " (NH4)2HPO4",
        "mut_aa_3": "Y",
        "wt_aa": "",
        "delet_start_2": "1",
        "protein_id_type_4": "",
        "mut_remark_3": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations",
        "deterg_concentr": "1.5",
        "position_2": "N-term",
        "mut_remark_4": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations",
        "deterg_concentr_unit": "%w/v",
        "lipid_concentr": "",
        "wt_aa_7": "S",
        "ins_end": "",
        "other_deterg": "",
        "aa_no_2": "579",
        "other_host_cell": "",
        "aamod_position": "",
        "concentr_2": "100",
        "aamod_start": "",
        "deletion_single": "",
        "ligand_id": "CHEMBL1270399",
        "presence_expr_4": "",
        "other_tag_2": "",
        "insert_pos_single": "",
        "other_tag_3": "",
        "deletion_2": "del_range",
        "fusion_prot_4": "",
        "prot_cleavage": "",
        "other_signal_3": "",
        "aamod": "",
        "presence_2": "YES",
        "concentr_unit_2": "mM",
        "ligand_name": "Compound 25",
        "aa_no_4": "669",
        "other_prot_cleavage_4": "",
        "wt_aa_4": "I",
        "ins_start_4": "",
        "other_tag": "",
        "protein_id_type": "",
        "signal_4": "",
        "wt_aa_3": "N",
        "other_deterg_type": "",
        "insert_pos_type_4": "",
        "delet_end_2": "568",
        "ph_range_one": "5.5",
        "insert_pos_single_4": "",
        "prot_cleavage_2": "",
        "mut_aa_2": "A",
        "delet_end": "",
        "aa_no_5": "675",
        "expr_other": "",
        "csrfmiddlewaretoken": "1YlXw92HRlfPT287BCVvtCBEXv6tqmHSA6tJzVqDKsckKaiXWdSgwOVHzxoH2bzM",
        "detergent": "",
        "mut_remark_5": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations",
        "additive_concentr": "0",
        "presence_4": "YES",
        "other_prot_cleavage_3": "",
        "concentr_5": "100",
        "lipid_concentr_unit": "",
        "mut_type": "",
        "other_tag_4": "",
        "crystal_method": "other [See next field]",
        "mut_aa": "",
        "tag_2": "",
        "aamod_pair_one_2": "644",
        "mut_aa_6": "A",
        "mut_aa_4": "A",
        "mut_remark": "",
        "crystal_remark": " The final protein:lipid ratio was 40:60 (w/w)",
        "presence": "",
        "chemical_comp_5": "Compound 25",
        "linker_seq_3": "",
        "mut_type_2": "Thermostabilising",
        "chem_enz_treatment": "Alkylation by Iodoacetamide",
        "tag": "",
        "concentr_unit": "",
        "presence_expr_3": "",
        "name_cont": "gpcrdb",
        "aa_no_3": "667",
        "chemical_comp_4": "PEG400",
        "fusion_prot": "",
        "protein_id_type_3": "",
        "concentr_unit_3": "mM",
        "uniprot": "grm5_human",
        "mut_type_5": "Thermostabilising",
        "lcp_conc_unit": "ratio",
        "ins_end_3": "679",
        "tag_4": "His(10)",
        "other_crystal_type": "",
        "other_signal_4": "",
        "other_host": "",
        "aamod_single": "",
        "date": "11/17/2016",
        "presence_expr_2": "",
        "linker_seq_4": "",
        "temperature": "20\u00b0C",
        "ins_start_3": "678",
        "fusion_prot_2": "",
        "concentr_unit_4": "%(v/v)",
        "deterg_conc_unit": "",
        "aa_no_6": "742",
        "delet_end_4": "836",
        "sol_remark": "",
        "aa_no_7": "753",
        "other_prot_cleavage": "",
        "aamod_2": "Disulfide bond",
        "lcp_lipid": "monoolein (9.9 MAG)",
        "deletion_single_2": "",
        "mut_remark_6": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations"
    },
    "modifications": [
        {
            "remark": "L-cystine",
            "position": [
                "pair",
                [
                    "644",
                    "733"
                ]
            ],
            "type": "Disulfide bond"
        }
    ],
    "mutations": [
        {
            "pos": "579",
            "mut": "A",
            "type": "Thermostabilising",
            "wt": "E",
            "remark": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations"
        },
        {
            "pos": "667",
            "mut": "Y",
            "type": "Thermostabilising",
            "wt": "N",
            "remark": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations"
        },
        {
            "pos": "669",
            "mut": "A",
            "type": "Thermostabilising",
            "wt": "I",
            "remark": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations"
        },
        {
            "pos": "675",
            "mut": "M",
            "type": "Thermostabilising",
            "wt": "G",
            "remark": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations"
        },
        {
            "pos": "742",
            "mut": "A",
            "type": "Thermostabilising",
            "wt": "T",
            "remark": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations"
        },
        {
            "pos": "753",
            "mut": "A",
            "type": "Thermostabilising",
            "wt": "S",
            "remark": "The mutations thermostabilized the receptor, significantly increased expression over wild-type protein, and in common with other StaR proteins we have used for fragment-screening, conferred an enhanced tolerance of high DMSO concentrations"
        }
    ],
    "solubilization": {
        "chem_enz_treatment": "Alkylation by Iodoacetamide",
        "deterg_concentr": "1.5",
        "deterg_type": "DDM",
        "addit_concentr_unit": "0",
        "deterg_concentr_unit": "%w/v",
        "solub_additive": "none",
        "additive_concentr": "0"
    },
    "error": 0,
    "contact_info": {
        "name_cont": "gpcrdb",
        "pi_name": "gpcrdb",
        "url": "gpcrdb.org",
        "date": "11/17/2016",
        "address": "\t\t\t\t\t\t\t",
        "pi_email": "info@gpcrdb.org"
    },
    "error_msg": [],
    "deletions": [
        {
            "end": "568",
            "type": "range",
            "origin": "user",
            "start": "1"
        },
        {
            "end": "836",
            "type": "range",
            "origin": "user",
            "start": "832"
        },
        {
            "end": "679",
            "type": "range",
            "origin": "insertion_3",
            "start": "678"
        }
    ],
    "crystallization": {
        "crystal_type": "lipidic cubic phase (LCP)",
        "ph_range_one": "5.5",
        "lcp_conc_unit": "ratio",
        "deterg_concentr": "1.5",
        "temperature": "20\u00b0C",
        "ph": "range_ph",
        "chemical_components": [
            {
                "component": "MES",
                "unit": "mM",
                "value": "100"
            },
            {
                "component": " (NH4)2HPO4",
                "unit": "mM",
                "value": "100-250"
            },
            {
                "component": "PEG400",
                "unit": "%(v/v)",
                "value": "24-34"
            },
            {
                "component": "Compound 25",
                "unit": "\u03bcM",
                "value": "100"
            }
        ],
        "deterg_concentr_unit": "%w/v",
        "crystal_method": "other [See next field]",
        "protein_concentr": "50",
        "protein_conc_unit": "mg/ml",
        "other_method": "two syringue method ",
        "lcp_add": "cholesterol ",
        "lcp_lipid": "monoolein (9.9 MAG)",
        "ph_range_two": "6.8",
        "lcp_conc": "1:10",
        "crystal_remark": " The final protein:lipid ratio was 40:60 (w/w)"
    }
}